 |
NHMRC Clinical Trials Centre |
 |
 |
 |
 |
 |
  |
|
| Research seminars | ||
| Medical Foundation Auditorium, 92–94 Parramatta Road, Camperdown | ||
| Seminars are open to all interested researchers and students. | ||
| Enquiries: Jenny Chow, 9562 5000, jenny.chow@ctc.usyd.edu.au | ||
| Thursday 10 December | ||
| Professor Thomas Lumley University of Washington |
12–1.30 | |
| Friday 4 December 2009 | ||
| Dr Chee Lee | Historical cross-trial comparisons for competing treatments in advanced breast cancer—an empirical analysis of bias |
3.30–5.00 |
| Friday 6 November 2009 | ||
| Ms Rhana Pike | Integrity and transparency in publishing biomedical research | 3.30–4.30 |
| Thursday 29 October 2009 | ||
| Professor Simon Eckermann | Translating trial evidence of binary event rates for clinical and economic evaluation: relative risk fallacies and odds solution |
3.30–5.00 |
| Details | ||
| Friday 2 October 2009 | 3.30–5.00 | |
| Dr Lisa Askie | Open access clinical trials through trial registries | |
| Ms Rhana Pike | Golden do’s and don’t’s of manuscript preparation | |
| Professor Val Gebski | Valid and dodgy statistics – getting it right | |
| Combined primary endpoints: flavor of the month | ||
| Ms Adrienne Kirby | Non-inferiority and equivalence trials: a user’s guide | |
| Friday, 3 July 2009 | 3.30–5.15 | |
| Dr Peter Grimison | Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours | |
| Professor Val Gebski | Final results of the Calypso phase III study | |
| Professor Val Gebski, Diana Zannino | Final results of the AGITG MAX trial | |
| 9 March 2009 | ||
Denis Xavier, St John’s Research Institute, India |
Challenges and opportunities in conducting clinical trials in developing countries | 12.30–1.30 |
| Friday, 6 March 2009 | 3.30–5.00 | |
| Kushwin Rajamani | Effects of fenofibrate on amputation events in type 2 diabetes mellitus (FIELD study): a randomised control trial | |
| Alberto Zambon | Contribution of lipoprotein abnormalities to macro- and microvascular residual risk | |
| Friday, 6 February 2009 | 3.30–5.15 | |
| Suzanne Dyer and Luke Marinovich | A systematic review and assessment of the evidence for the clinical effectiveness of FDG-PET in staging colorectal cancer and melanoma |
|